Striving for standards in bioequivalence assessment: a review.
作者信息
Schulz H U, Steinijans V W
机构信息
Department of Angiology and Geriatrics, Medical University of Lübeck, Germany.
出版信息
Int J Clin Pharmacol Ther Toxicol. 1992;30 Suppl 1:S1-6.
PMID:1601528
Abstract
摘要
相似文献
1
Striving for standards in bioequivalence assessment: a review.生物等效性评估标准的探讨：综述
Int J Clin Pharmacol Ther Toxicol. 1992;30 Suppl 1:S1-6.
2
Therapeutic inequivalence of pharmaceutical alternates.药物替代物的治疗不等效性。
Am Pharm. 1985 Apr;NS25(4):28-39.
3
Striving for standards in bioequivalence assessment: a review.生物等效性评估标准的探讨：综述
Int J Clin Pharmacol Ther Toxicol. 1991 Aug;29(8):293-8.
4
Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.人体志愿者中地瑞茶碱 - 地高辛生物（不）等效性评估。II. 兔作为定性动物模型的评价
Methods Find Exp Clin Pharmacol. 1986 May;8(5):303-7.
5
[Bioequivalence studies of pharmaceutical preparations].[药物制剂的生物等效性研究]
Cas Lek Cesk. 2007;146(5):431-3.
6
Bioavailability and bioequivalence of topical glucocorticoids.局部用糖皮质激素的生物利用度和生物等效性。
Eur J Pharm Biopharm. 2008 Mar;68(3):453-66. doi: 10.1016/j.ejpb.2007.08.007. Epub 2007 Aug 8.
7
Bioavailability and bioequivalence requirements: abbreviated applications. Final Rule.生物利用度和生物等效性要求：简略申请。最终规则。
Fed Regist. 2002 Dec 19;67(244):77668-75.
8
Comparative bioavailability of two brands of chlorpropamide in Kenyans.肯尼亚人使用的两种品牌氯磺丙脲的相对生物利用度
East Afr Med J. 1989 Oct;66(10):663-8.
9
[The bioavailability and bioequivalence of dignoxin and digitoxin preparations].[地高辛和洋地黄毒苷制剂的生物利用度和生物等效性]
Pharm Acta Helv. 1979;54(6):173-9.
10
A review of absorption characteristics of microemulsion cyclosporine products over the last 2 years in Indian subjects.过去两年印度受试者中微乳环孢素产品吸收特性的综述。
J Indian Med Assoc. 1999 Jul;97(7):292-3.
引用本文的文献
1
Relative bioavailability and pharmacodynamic effects of methantheline compared with atropine in healthy subjects.与阿托品相比，健康受试者中甲硫酸新斯的明的相对生物利用度和药效学作用。
Eur J Clin Pharmacol. 2012 Nov;68(11):1473-81. doi: 10.1007/s00228-012-1286-6. Epub 2012 Apr 21.
2
Relative bioavailability of different oral sustained release oxprenolol tablets.不同口服缓释氧烯洛尔片的相对生物利用度。
Eur J Drug Metab Pharmacokinet. 1998 Apr-Jun;23(2):178-84. doi: 10.1007/BF03189336.
3
Tmax: an unconfounded metric for rate of absorption in single dose bioequivalence studies.Tmax：单剂量生物等效性研究中吸收速率的无混杂因素指标。
Pharm Res. 1996 Feb;13(2):324-8. doi: 10.1023/a:1016019904520.
4
Pharmacokinetics of carbamazepine. Part I: A new bioequivalency parameter based on a relative bioavailability trial.
Eur J Drug Metab Pharmacokinet. 1994 Oct-Dec;19(4):319-25. doi: 10.1007/BF03188858.
Zotero 插件